As of January 31st, 2023 all research on human subjects with medicinal products in the EU needs to be submitted via the EMA Clinical Trial Information System, the CTIS. Up to now, in the current transition period, organizations focussed on the setup of the optimal organization model in CTIS, and the preparation for their first submissions via the system.